Search results for: Spain
Filter search results
Around The World in HTAs: Spain – Are We There Yet?
15 March 2023
The health system in the country Spain has a universal national health system (NHS) mainly funded by taxes. The Spanish NHS is organised in two levels, national (represented by the…
Promoting Evidence-based Health Care Policy in Spain: 6th Annual Workshop with EvaluAES
10 April 2017
…debate. The generation of evidence to support health care policies in Spain is well established, the next challenge for Spain, like many other countries, is the implementation of evidence-based policies….
Promoting Evidence-based Health Care Policy in Spain: EvaluAES 7th Annual Workshop
10 May 2018
…Public Health in Madrid, Spain. EvaluAES is supported by the Spanish Health Economics Association (AES). It seeks to disseminate research on the economics of health and to establish collaborations and joint learnings across…
Important Variations in Access to Orphan Drugs in France, Italy, Germany, Spain and the UK
14 March 2017
A new OHE report compares the availability and access of orphan medicinal products (OMPs) in the UK, France, Germany, Italy and Spain. A new OHE Consulting Report has been published…
The Spanish Medicines Market Today
9 February 2011
…major change in Spain’s medicines market, with key events occurring in 2002, 2004, 2006 and 2010. In 2002, important responsibilities for health care were devolved to Spain’s autonomous regions. Although…
‘HispaNICE’: the Creation of an ‘Independent Authority for the Evaluation of Health Practices and Policies’ Gathers Momentum
24 February 2021
This blog summarises an initiative taken by more than 300 health economists and experts in support of the creation of an independent health technology assessment agency in Spain. Over three…
New Paper in Quality of Life Research – Can Patients’ Self-Reported Pain be Compared and Aggregated in Multi-Country Studies?
30 March 2017
…Japan and Spain) on the EQ-5D. Existing data sets were used to explore differences in responses on the EQ-5D descriptive system between Japan (3L and 5L), the UK (3L), England…
Access Mechanisms for Orphan Drugs: A Comparative Study of Selected European Countries
1 November 2009
This study compares pricing and reimbursement (P&R) policy for 43 orphan medicinal products (OMPs) across seven EU Member States: France, Germany, Italy, The Netherlands, Spain, Sweden and the UK. Examined…
OHE at HTAi 2017: Meet the Team
13 June 2017
…This study compares the availability and access to orphan medicinal products in the UK (England, Scotland and Wales), France, Germany, Italy and Spain. Orphan drugs are authorised in all EU…